NEW FUNDING: Why We Invested in Qure4U  Read More

NEWS: Medly Pharmacy Announces Agreement to Acquire Pharmaca: Medly Pharmacy Announces Agreement to Acquire Pharmaca Expanding Free Same-Day Delivery to Include Health and Wellness Products  Read More

NEW FUNDING: Why We Invested in US Mobile  Read More

ASK JENNY ANYTHING: Volition Venture Partner Jenny Fleiss answers your questions: What Should I Expect During Investor Diligence?  Read More

SCALING SUCCESS PODCAST: Sean Cantwell interviews Paul Melchiorre for Scaling Success  Read More

Volition
Michael Brannan
Analyst

 “As you walk down the fairway of life you must smell the roses, for you only get to play one round.”

– Ben Hogan

discover

Michael joined Volition Capital in 2021 as an Analyst on the Software and Tech-Enabled-Services Deal Team. He’s responsible for sourcing and providing due diligence on new investment opportunities within software and tech-enabled service businesses.

More about Michael
PRIOR EXPERIENCE & EDUCATION
  • Graduated from the University of Notre Dame with a degree in Finance in 2021
  • Interned at the Duke and Notre Dame Investment Offices
  • Interned at hedge fund Bridger Capital in 2020 before his senior year at Notre Dame
FUN FACTS ABOUT MICHAEL
  • He was a practice player on the Notre Dame women’s basketball team when they won the national championship in 2018
  • He loves playing sports and getting exercise (basketball, golf, and football specifically)
  • He and his family have watched the Harry Potter movies about 15-20 times each
Grow with Opportunity

“I wanted to work in growth equity because it allowed me the opportunity to work with different founders and companies, helping them to achieve their goals and make a difference in their respective fields.”